기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
심뇌혈관질환 고위험군 중 치료연속자와 치료불연속자 간의 특성 비교
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • 심뇌혈관질환 고위험군 중 치료연속자와 치료불연속자 간의 특성 비교
저자명
박정숙,권영숙,오윤정,Park. Jeong-Sook,Kwon. Young-Sook,Oh. Yun-Jung
간행물명
保健敎育健康增進學會誌
권/호정보
2009년|26권 2호|pp.135-148 (14 pages)
발행정보
한국보건교육건강증진학회
파일정보
정기간행물|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

Objectives: The purpose of this study is to identify the characteristics between therapy continuity group and therapy discontinuity group and to develop management program for Korean patients with hypertension and diabetes. Methods: The subject of the study were 109 therapy continuity and 66 therapy discontinuity of Korea hypertension diabetes Daegu initiative. The data collection was performed from December 5 to December 30, 2008. Analysis of data was done by using descriptive statistics, chi-square test, t-test and ANCOVA with SPSS program. Results: 1) The groups were significantly correlated with such variables systolic BP(F=4.518, p=0.035) and diastolic BP(F=17.793, p=0.000). 2) The groups with hypertensive were significantly correlated with such variables perceived susceptibility of disease($chi^2$=25.053, p=0.000), perceived barrier of health behavior($chi^2$=12.584, p=0.006), drinking($chi^2$=27.545, p=0.000), diet($chi^2$=8.645, p=0.013), regular taking medicine($chi^2$=92.415, p=0.000) and regular measurement of BP($chi^2$=6.045, p=0.049). 3) The groups with diabetic were significantly correlated with such variables perceived seriousness of disease($chi^2$=6.128, p=0.047), perceived susceptibility of disease($chi^2$=8.079, p=0.018), health knowledge and attitude(F=8.418, p=0.006), drinking($chi^2$=6.276, p=0.043), diet($chi^2$=7.275, p=0.026), regular taking medicine($chi^2$=33.083, p=0.000) and regular measurement of glucose($chi^2$=7.233, p=0.027). Conclusion: The above findings indicate that it is necessary to develop and apply special management programs according to the therapy discontinuity group.